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Excitation-contraction coupling (ECC) in the cardiac myocyte is mediated by a
number of highly integrated mechanisms of intracellular Ca2+ transport. Voltage- and
Ca2+-dependent L-type Ca2+ channels (LCCs) allow for Ca2+ entry into the myocyte,
which then binds to nearby ryanodine receptors (RyRs) and triggers Ca2+ release from
the sarcoplasmic reticulum in a process known as Ca2+-induced Ca2+ release. The highly
coordinated Ca2+-mediated interaction between LCCs and RyRs is further regulated by
the cardiac isoform of the Ca2+/calmodulin-dependent protein kinase (CaMKII). Because
CaMKII targets and modulates the function of many ECC proteins, elucidation of its
role in ECC and integrative cellular function is challenging and much insight has been
gained through the use of detailed computational models. Multiscale models that can
both reconstruct the detailed nature of local signaling events within the cardiac dyad
and predict their functional consequences at the level of the whole cell have played an
important role in advancing our understanding of CaMKII function in ECC. Here, we review
experimentally based models of CaMKII function with a focus on LCC and RyR regulation,
and the mechanistic insights that have been gained through their application.
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INTRODUCTION
Cardiac electrophysiology is a discipline with a rich and deep
history dating back more than a half-century. Much of our
understanding of fundamental biological mechanisms in this
field comes from experimental research coupled with integrative
mathematical modeling. The goal of this modeling has been to
achieve a quantitative understanding of the functional mecha-
nisms and relationships that span from the level of molecular
structure and function to integrated cardiac myocyte behavior in
health and disease. Advances in computational techniques and
hardware have led to the recent development of many sophis-
ticated large-scale models of heart tissue, in which these elec-
trophysiological myocyte models are the fundamental building
blocks. Some of the most fundamental advances in computa-
tional cell biology, including formulation of dynamic models of
voltage-gated ion channels, mitochondrial energy production,
membrane transporters, intracellular Ca2+ dynamics, and sig-
nal transduction pathways have emerged from this field. One
such signaling pathway is that involving the Ca2+/calmodulin
(CaM)-dependent protein kinase (CaMKII), which targets and
functionally regulates a number of proteins that are central to
cardiac excitation-contraction coupling (ECC), and has been
identified as a promising new target for antiarrhythmic therapy
in patients with heart failure (Rokita and Anderson, 2012). This
review focuses on the role of experimentally based models of
CaMKII function with a focus on L-type Ca2+ channel (LCC)
and ryanodine receptor (RyR) regulation, and the mechanistic
insights that have been gained through their application.
The nature of ECC is linked closely to the micro-anatomical
structure of the cell. Sarcomeres, the basic units of contractile pro-
teins, are bounded on both ends by the t-tubular system (Soeller
and Cannell, 1999; Bers, 2001). The t-tubules extend deep into
the cell and approach the sarcoplasmic reticulum (SR), an intra-
cellular luminal organelle involved in the uptake, sequestration
and release of Ca2+. The junctional SR (JSR) is the portion of
the SR most closely approximating (within 12–15 nm Franzini-
Armstrong et al., 1999) the t-tubules. The close proximity of
these two structures forms a microdomain known as the dyad.
RyRs are Ca2+-sensitive Ca2+-release channels which are pref-
erentially located in the dyadic region of the JSR membrane.
In addition, LCCs are preferentially located within the dyadic
region of the t-tubules, where they are in close opposition to
the RyRs. The process by which Ca2+ enters the myocyte dur-
ing the initial depolarization stages of the action potential (AP)
via voltage-gated LCCs and triggers the opening of RyRs, and
hence JSR Ca2+ release, is known as Ca2+-induced Ca2+ release
(CICR) and comprises the initial transduction event of ECC.
Recent imaging studies have demonstrated that dyadic clefts are
small, where junctions contain an average of 14 RyRs, with some
clusters incompletely filled with RyRs, and with a large fraction of
clusters closely spaced within 20–50 nm, suggesting that smaller
clusters may act together to function as a single site of CICR
(Baddeley et al., 2009; Hayashi et al., 2009).
The elucidation of CICR mechanisms became possible with
the development of experimental techniques for simultaneous
measurement of L-type Ca2+ current (ICaL) and Ca2+ transients,
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and detection of local Ca2+ release events known as Ca2+ sparks
(Cheng et al., 1993). The evidence for tight regulation of SR Ca2+
release by triggering LCC current (for a review see Soeller and
Cannell, 2004) gave rise to and later verified the local control
theory of ECC (Stern, 1992). The mechanism of local control
predicts that tight regulation of CICR is achieved because LCCs
and RyRs are regulated by local dyadic Ca2+. It is now widely
accepted that CaMKII, a ubiquitous Ca2+-dependent protein that
can become highly activated in the dyad (Currie et al., 2004;
Hudmon et al., 2005; Maier, 2005), can modulate CICR via phos-
phorylation of a number of ECC proteins including LCCs and
RyRs (Maier and Bers, 2007). CaMKII modulates LCCs via a
Ca2+-dependent positive-feedback regulatory mechanism known
as ICaL facilitation (Anderson et al., 1994; Xiao et al., 1994;
Yuan and Bers, 1994). This is observed as a positive staircase
in current amplitude in combination with a slower rate of ICaL
inactivation upon repeated membrane depolarization. Although
multiple mechanisms have been suggested to underlie ICaL facili-
tation, experiments from Dzhura et al. (2000) demonstrated that
CaMKII-dependent ICaL facilitation alters the behavior of LCCs
such that high activity gating modes with prolonged open times
are more likely to occur. The specific functional effects of CaMKII
phosphorylation of RyRs remain controversial. CaMKII has been
shown to increase (e.g., Wehrens et al., 2004) or decrease (e.g.,
Lokuta et al., 1995) the channel open probability. Inconsistencies
in experimental findings regarding the role of CaMKII on RyR
function may not be surprising given the methodological differ-
ences between the studies. In addition, the high sensitivity of RyR
gating to both cytosolic and SR Ca2+ makes it difficult to interpret
experiments in which these Ca2+concentrations are not tightly
controlled. In one well designed study, Guo et al. (2006) devel-
oped an experimental protocol that overcame this challenge and
provided strong evidence that CaMKII mediated phosphoryla-
tion of RyRs increases channel open probability. Such an increase
is also consistent with transgenic studies of CaMKII overexpres-
sion which report increased Ca2+ spark frequency in response
to elevated CaMKII activity (Maier et al., 2003; Kohlhaas et al.,
2006).
The CaMKII holoenzyme exists as an elaborate macromolec-
ular complex consisting of two stacked ring-shaped hexamers
(Hudmon and Schulman, 2002). Each of the holoenzyme’s 12
subunits can be activated through the binding of Ca2+-bound
CaM (Ca2+/CaM) to the CaMKII regulatory domain in response
to beat-to-beat transient increases of intracellular Ca2+ con-
centration. In cardiac myocytes, an activated CaMKII molecule
can undergo autophosphorylation by neighboring subunits at
threonine amino acid residues in its regulatory domain, which
allows the kinase to retain activity even upon dissociation of
Ca2+/CaM (Meyer et al., 1992). An alternative mechanism of
oxidative CaMKII activation has also been identified (Erickson
et al., 2008). As a result of the fact that CaMKII regulates multi-
ple protein targets (both directly and indirectly involved in ECC),
and that the effect of CaMKII mediated phosphorylation on any
particular target protein may involve complex alterations in bio-
physical function (e.g., mode-switching behavior of LCCs), the
task of elucidating its role in cardiac function in both normal and
failing hearts continues to present great challenges and cannot
be accomplished via experiments alone. Some recent advances in
understanding the mechanisms of CaMKII-dependent function
in cardiac myocytes have been discovered by coupling mathemat-
ical models to experimental observations. In this review we will
focus on key models of CaMKII-mediated regulation of LCCs
and RyRs arising from both Ca2+/CaM-dependent as well as
oxidative activation pathways, the integration of such models into
whole-cell models, and the mechanistic insights that have been
obtained from this work. A summary of the models covered here
is provided in Table 1.
MODELS OF Ca2+/CaM-DEPENDENT CaMKII ACTIVATION
AND REGULATION
The first model of CaMKII signaling within the context of ECC
integrated into the cardiac myocyte was presented by Hund and
Rudy (2004). This model, known as the HRd model, incorpo-
rates a scheme based on the work of Hanson et al. (1994), where
a single population of CaMKII transitions from an inactive to
active state in response to elevated subspace Ca2+ levels. CaMKII
activity is assumed to modify the function of LCCs and RyRs by
slowing their inactivation kinetics, thereby enhancing ICaL and
JSR Ca2+ release, respectively. SR Ca2+ uptake was also enhanced
by CaMKII activity via its action on phospholamban (PLB) and
the SR Ca2+-ATPase (SERCA). The model predicted that CaMKII
plays a critical role in the rate-dependent increase of the cytoso-
lic Ca2+ transient by increasing ECC gain, but that it does not
play a significant role in rate-dependent changes of AP duration.
Similar results were obtained in the human cardiac AP model
of O’hara et al. (2011), which incorporates the role of CaMKII
phosphorylation on LCCs, the fast Na+ current (INa), and the
transient outward K+ current (Ito1). The HRd model was later
updated and used to investigate the role of altered CaMKII sig-
naling in the canine infarct border zone (Hund et al., 2008).
Experimentally measured elevation of CaMKII autophosphory-
lation in this region is reproduced by the model, which indicates
that hyperactive CaMKII impairs Ca2+ homeostasis by increasing
Ca2+ leak from the SR. A number of additional modeling studies
have focused on the role of CaMKII on various aspects of intracel-
lular Ca2+ dynamics. Iribe et al. (2006) incorporated a conceptual
CaMKII model into their previous myocyte model (Noble et al.,
1991) combined with a model of mechanics (Rice et al., 1999) in
order to investigate its role on SR Ca2+ handling and interval-
force relations. They found that a relatively slow time-dependent
inactivation of CaMKII allowed for the reconstruction of a vari-
ety of interval-force relations, including alternans. Koivumaki
et al. (2009) built a model of the murine cardiac myocyte to
analyze genetically engineered heart models in which CaMKII-
mediated phosphorylation of LCCs is disrupted or CaMKII is
overexpressed. They demonstrated how these genetic manipula-
tions lead to the observed experimental phenotypes as a result
of autoregulatory mechanisms that are inherent in intracellular
Ca2+ cycling (e.g., steady-state regulation of SR content via Ca2+
release dependent inactivation of LCCs), and that disruption of
the regulatory system itself (e.g., via CaMKII overexpression)
leads to the most aberrant physiological phenotypes. Livshitz and
Rudy (2007) formulated a new model of SR Ca2+ release kinet-
ics and incorporated it into the HRd model in order to better
understand regulation of Ca2+ and electrical alternans under var-
ious pacing protocols. They found that increased CaMKII activity
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Table 1 | Key features of CaMKII models in cardiac ECC.
Cell model Species Parent ECC model CaMKII activation model Included CaMKII targets
Hund and Rudy, 2004 Dog Luo and Rudy, 1994 Hanson et al., 1994 LCCs, RyRs, SERCA/PLB
Iribe et al., 2006 Guinea pig Noble et al., 1991 Conceptual kinetic model LCCs, RyRs, SERCA
Livshitz and Rudy, 2007 Guinea pig/Dog Luo and Rudy, 1994; Hund
and Rudy, 2004
Hanson et al., 1994 LCCs, RyRs, SERCA/PLB
Grandi et al., 2007 Rabbit Shannon et al., 2004 Static formulation
Target parameters adjusted
ICaL, INa, Ito
Saucerman and Bers, 2008 Rabbit Shannon et al., 2004 Adapted from Dupont et al.
(2003), Gaertner et al. (2004)
no target
Hund et al., 2008 Dog Hund and Rudy, 2004 Hanson et al., 1994 LCCs, RyRs, SERCA/PLB, INa
Koivumaki et al., 2009 Mouse Bondarenko et al., 2004 Bhalla and Iyengar, 1999 LCCs, RyRs, SERCA/PLB
Hashambhoy et al., 2009 Dog Greenstein and Winslow,
2002
Dupont et al., 2003 LCCs
Christensen et al., 2009 Dog Hund et al., 2008 Hanson et al., 1994 LCCs, RyRs, SERCA/PLB, INa
Soltis and Saucerman, 2010 Rabbit Saucerman and Bers, 2008 Dupont et al., 2003; Gaertner
et al., 2004
LCCs, RyRs, PLB, INa, Ito
Hashambhoy et al., 2010 Dog Hashambhoy et al., 2009 Dupont et al., 2003 LCCs, RyRs, PLB
O’hara et al., 2011 Human Hund and Rudy, 2004; Decker
et al., 2009
Hund and Rudy, 2004 LCCs, PLB, INa, Ito
Hashambhoy et al., 2011 Dog Hashambhoy et al., 2010 Dupont et al., 2003 LCCs, RyRs, PLB, INa
Zang et al., 2013 Dog Hund and Rudy, 2004 Hanson et al., 1994 LCCs, RyRs, INa, Ito, IK1, SERCA
Morotti et al., 2014 Mouse Soltis and Saucerman, 2010 Dupont et al., 2003; Gaertner
et al., 2004
LCCs, RyRs, PLB, INa, Ito,IK1, INCX
leads to increased alternans magnitude as well as the appearance
of both Ca2+ and electrical alternans at lower pacing rates (where
they would not normally occur). This model identifies Ca2+ alter-
nans as the underlyingmechanism for electrical alternans, both of
which were eliminated with CaMKII inhibition, suggesting this as
an antiarrhythmic strategy. Zang et al. (2013) recently developed
a new canine myocyte model, also based on the HRd model, to
study the role of upregulated CaMKII in heart failure. Similarly,
they find that enhanced RyR Ca2+-sensitivity and SR Ca2+ leak
mediated by CaMKII overexpression alters Ca2+ handling in a
manner that promotes alternans, while AP prolongation occurs
primarily due to an associated down regulation of K+ currents.
Interestingly, they find that blocking SR Ca2+ leak restores con-
traction and relaxation function, but does not eliminate alternans
completely.
Grandi et al. (2007) developed a model of CaMKII overexpres-
sion in the rabbit ventricular myocyte, which incorporates the
functional effects of CaMKII-mediated phosphorylation of LCCs,
as well as INa and Ito1. This model shows that while CaMKII-
mediated action on LCCs prolongs the AP, the combined effect of
CaMKII on all three of the targets studied leads to AP shortening.
While this study was primarily motivated by and focused on
the functional role of CaMKII-mediated regulation of INa (see
accompanying article in this series by Grandi and Herren),
it clearly demonstrates that the multiple targets of CaMKII
interact to produce net alterations of integrated cellular function
which are difficult to predict from knowledge if its functional
effects on isolated individual targets. Saucerman and Bers (2008)
developed and incorporated models of CaM, CaMKII, and
calcineurin (CaN) into the rabbit ventricular myocyte model of
Shannon et al. (2004) in order to better understand the functional
consequences of the different affinities of CaM for CaMKII and
CaN during APs. The model predicts that the relatively high Ca2+
levels that are achieved in the cardiac dyad lead to a high degree
of CaM activity which results in frequency-dependent CaMKII
activation and constitutive CaN activation, whereas the lower
Ca2+ levels in the cytosol only minimally activate CaM, which
allows for gradual CaN activation, but no significant activation of
CaMKII. The prediction that robust beat-to-beat oscillations of
CaMKII activity occur in the dyad (i.e. in the vicinity of RyRs and
LCCs) but not in the cytosol is a key factor that would influence
the way in which local signaling mechanisms would be incor-
porated into models that followed that included detailed recon-
struction of dyadic Ca2+ dynamics. In one such model, Soltis
and Saucerman (2010) integrated dynamic CaMKII-dependent
regulation of LCCs, RyRs, and PLB with models of cardiac ECC,
CaMKII activation, and β-adrenergic activation of protein kinase
A (PKA). In this model phosphorylation of all CaMKII substrates
exhibits positive frequency dependence similar to that observed
in experiments (De Koninck and Schulman, 1998). However,
both CaMKII activity and target protein phosphorylation levels
adapt to changes in pacing rate with distinct kinetics (see Figure
2 of Soltis and Saucerman, 2010). CaMKII-mediated phosphory-
lation is relatively fast at LCCs, slower at RyRs, and very slow at
PLB. Additionally, the model predicts a high degree of phospho-
rylation of LCCs in control conditions, but a moderate amount
of phosphorylation of RyRs and PLB (e.g., PLB phosphorylation
<10% at all frequencies). In addition, this study predicts a novel
mechanism in which CaMKII and PKA synergize to form a
positive feedback loop of CaMKII-Ca2+-CaMKII regeneration.
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Furthermore, this model predicts that CaMKII-mediated hyper-
phosphorylation of RyRs, which renders them leaky, may be
a proarrhythmic trigger via induction of delayed afterdepolar-
izations (DADs). Recently, Morotti et al. (2014) modified the
Soltis and Saucerman (2010) rabbit model to further investigate
the arrhythmogenic role of another synergistic interaction
in mouse ventricular myocytes. This synergism is that of the
positive feedback loop of CaMKII-Na+-Ca2+-CaMKII in which
CaMKII-dependent increases in intracellular Na+ level perturbs
Ca2+ homeostasis and CaMKII activation. Simulation results
fromMorotti et al. (2014) demonstrate that the feedback between
disrupted Na+ fluxes and CaMKII signaling is exaggerated when
CaMKII is overexpressed. Under this condition, and upon an
increase in intracellular Na+ concentration,the model predicts
Ca2+ overload and enhancement of CaMKII activity which in
turn increases spontaneous Ca2+ release events via an increase in
RyR phosphorylation. This CaMKII-dependent hyperphospho-
rylation of RyRs exacerbates the associated electrophysiological
instability as simulated by the occurrence of DADs (see Figure
7 of Morotti et al., 2014). In this model, the DADs do not
occur when CaMKII target phosphorylation is clamped to basal
levels.
Recently, Hashambhoy et al. (2009) developed a biochemically
and biophysically detailed model of CaMKII-mediated phospho-
rylation of LCCs. Themodel includes descriptions of the dynamic
interactions among CaMKII, LCCs, and phosphatases as a func-
tion of dyadic Ca2+ and CaM levels, and has been incorporated
into an integrative model of the canine ventricular myocyte with
stochastic simulation of LCC and RyR channel gating within a
population of release sites based on the theory of local control of
ECC (Greenstein and Winslow, 2002). A schematic representa-
tion of one such model Ca2+-release site is shown in Figure 1A.
This CaMKII-LCC model is formed by the integration of three
modules: a CaMKII activity model which reflects the different
structural and functional states of the kinase based on the work
of Hudmon and Schulman (2002) and Dupont et al. (2003), an
LCC phosphorylation model derived from studies of facilitation
in LCC mutants (Grueter et al., 2006; Lee et al., 2006), and a pre-
viously developed LCC gating model (Jafri et al., 1998; Greenstein
and Winslow, 2002). In this model it is assumed that there is one
12-subunit CaMKII holoenzyme tethered to each LCC (Hudmon
et al., 2005), each CaMKII monomer can transition among a
variety of activity states (see Figure 2 of Hashambhoy et al.,
2009), and CaMKII monomers can catalyze phosphorylation of
individual LCCs. The LCC gating model reflects two forms of
channel gating, mode 1 (normal activity) and mode 2 (high activ-
ity with long openings). In the model, LCC phosphorylation
promotes transitions of LCCs from mode 1 to mode 2 gating,
based on experimental observations with constitutively active
CaMKII (Dzhura et al., 2000). This model demonstrates that
these CaMKII-dependent shifts of LCC gating patterns into high
activity gating modes may be the underlying mechanism of ICaL
facilitation. In addition, the model predicts that this CaMKII-
mediated shift in LCC gating leads to an apparent increase in
the speed of both ICaL inactivation and recovery from inacti-
vation, both of which are experimentally associated with ICaL
facilitation, with no change to the underlying intrinsic LCC
inactivation kinetics. Hashambhoy et al. (2010) further expanded
this model to include CaMKII-dependent regulation of RyRs. In
this model update, RyR phosphorylation is modeled as a function
of dyadic CaMKII activity and it is assumed that RyR sensitiv-
ity to dyadic Ca2+ is increased upon phosphorylation, the degree
to which is constrained by experimental measurements of Ca2+
spark frequency and steady state RyR phosphorylation (Guo et al.,
2006). This study demonstrated that under physiological condi-
tions, CaMKII phosphorylation of LCCs ultimately has a greater
effect on ECC gain, RyR leak flux, and AP duration as com-
pared with phosphorylation of RyRs (Figure 1B). AP duration
at 90% repolarization (APD90) correlates well with a CaMKII-
mediated shift in modal gating of LCCs (Figure 1C). A modest
additional increase in LCC phosphorylation, and hence mode 2
gating, beyond that shown in Figure 1C leads to the appearance
of early afterdepolarizations (EADs) in simulated APs (see Figure
5 of Hashambhoy et al., 2010). The results of these model anal-
yses suggest that LCC phosphorylation sites may in fact prove to
be a more effective target than those on the RyR for modulat-
ing diastolic RyR-mediated Ca2+ leak and preventing abnormal
proarrhythmic cellular depolarization.
MODELS OF OXIDATIVE CaMKII ACTIVATION AND
REGULATION
The modeling studies described above focus on the role
of CaMKII-mediated regulation of its targets via the classi-
cal Ca2+/CaM-dependent activation pathway which involves
CaMKII autophosphorylation. Recently a novel mechanism
for oxidative CaMKII activation was discovered in the heart
(Erickson et al., 2008). This alternative oxidation-dependent
pathway involves the oxidation of CaMKII at specific methio-
nine residues, which has been shown to produce persistent
kinase activity and increase the likelihood of arrhythmias (Xie
et al., 2009; Wagner et al., 2011). These new findings impli-
cate oxidative CaMKII activation as a putative mechanistic link
between the accumulation of reactive oxygen species (ROS)
and life-threatening cardiac arrhythmias (Erickson et al., 2011).
Therefore, developing a quantitative understanding of the role
of CaMKII oxidation in regulating cardiac ECC requires the
integration of computational models that link cellular ROS and
redox balance, CaMKII activity and function, ECC, and whole-
cell electrophysiology. Suchmodels will prove to be powerful tools
for teasing out important mechanisms of arrhythmia in heart
disease.
In one recent study, Christensen et al. (2009) developed a
deterministic model of oxidative CaMKII activation based on
their own experimental findings to study the role of this signaling
pathway in the canine infarct border zone following myocar-
dial infarction. A new simplified model of CaMKII activation
was developed based on the work of Dupont et al. (2003), and
incorporated into a model of a single cardiac fiber. Each myocyte
within the fiber model was represented by the Hund et al. (2008)
model, which as noted above, incorporates CaMKII effects on INa,
ICaL, SR Ca2+ leak and uptake, as well as ion channel remod-
eling associated with the infarct border zone. Simulation results
demonstrate that enhanced oxidative CaMKII activity is asso-
ciated with reduced conduction velocity, increased refractory
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FIGURE 1 | (A) Schematic representation of the cardiac dyad. Ca2+ ions
pass through the LCC and enter the dyad, where they bind to RyRs,
triggering CICR. The activity of each CaMKII monomer is a function of
dyadic Ca2+ levels. Ca2+ ions released from the SR diffuse out of the dyad
into the bulk myoplasm. (B) Simulated results from a 1-Hz AP-pacing
protocol under different LCC and/or RyR phosphorylation conditions.
(C) APD90 as a function of average LCC phosphorylation levels. Fully
phosphorylated LCCs gate in mode 2, which exibit long-duration openings.
(A) Reprinted with permission from Hashambhoy et al. (2009). Copyright
2009 Elsevier. (B,C) Reprinted with permission from Hashambhoy et al.
(2010). Copyright 2010 Elsevier.
periods, and a greater likelihood of conduction block formation.
Furthermore, CaMKII inhibition in the model improves conduc-
tion and reduces vulnerability to conduction block and reentry.
The results of Christensen et al. (2009) are attributed primarily
to CaMKII-mediated regulation of INa kinetics and availability.
They note that CaMKII activation will also impact ECC proteins
in ways that may promote arrhythmias, but these mechanisms
were not explored in detail in this model.
Along these lines, Foteinou et al. (2013) have recently devel-
oped a novel stochastic model of CaMKII activation (Figure 2A)
that reflects the functional properties of the cardiac isoform
including both the canonical phosphorylation-dependent acti-
vation pathway and the newly identified oxidation-dependent
pathway. This model builds upon the work of Hashambhoy et al.
(2010, 2011) in order to incorporate recent experimental data for
CaM affinity and autophosphorylation/oxidation rates measured
specifically for the cardiac isoform of CaMKII (Gaertner et al.,
2004; Erickson et al., 2008). Predicated upon this, the authors
implemented the four-state deterministic activation model of
Chiba et al. (2008) within a stochastic framework that is con-
strained by the geometry of the CaMKII holoenzyme. This was
accomplished by restricting CaMKII autophoshorylation events
to occur only between adjacent CaMKII subunits. The stochas-
tic activation model was further modified by including oxidized
active states in addition to a Ca2+/CaM-bound active state, an
autophosphorylated Ca2+/CaM-bound state, and an autophos-
phorylated Ca2+/CaM-dissociated state (i.e., an autonomous
active state). Following incorporation into the canine cardiac
myocyte model (Hashambhoy et al., 2011), Foteinou et al. (2013)
obtain steady state APs at a pacing cycle length (PCL) of 2 s
as illustrated in Figure 2B. This model predicts increased like-
lihood of EADs under this protocol upon increased oxidative
stress (application of 200µM H2O2, which is at the high end of
pathophysiological levels), as shown in Figure 2C. Notably, the
model simulates no EADs in the presence of ROS at a PCL of
1 s, which is consistent with the experimentally measured rate-
dependence of EADs in the presence of 200µM H2O2 (Zhao
et al., 2012). The model predicts that EADs result from both
enhanced CaMKII-dependent shifts of LCCs into highly active
mode 2 gating and a progressively increased late component
of Na+ current (INaL). The simulated increase in ICaL via oxi-
dized CaMKII corroborates the experimental findings of Song
et al. (2010) who demonstrated that oxidative CaMKII activa-
tion is involved in the regulation of LCCs. In particular, the in
silico model of H2O2 exposure discussed here predicts that the
fraction of LCCs gaiting in mode 2 will shift from 5% in con-
trol (absence of ROS) to 7% upon this increase in ROS. Using
this model, the simulated diastolic RyR leak also increases in
response to oxidative stress (∼44%) primarily as an indirect con-
sequence of increased Ca2+ influx via LCCs. Wagner et al. (2011)
recently observed a ∼15-fold H2O2-mediated increase in SR
Ca2+ leak, which is far greater than that produced in this model
(<2-fold). They, however, provide additional evidence indicating
that their observed increase in Ca2+ leak does not require the
presence of CaMKII, suggesting an important role for CaMKII-
independent mechanisms of ROS-mediated alteration of cardiac
ECC as well.
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FIGURE 2 | (A) State diagram of the stochastic CaMKII activation model of
Foteinou et al. (2013). Prior to the introduction of Ca2+/CaM, all of the CaMKII
subunits are in the inactive form (state I). Activation occurs upon binding of
Ca2+/CaM (state B), autophosphorylation (state P), and oxidation (state OxB).
Autonomous active states (Ca2+/CaM-unbound) can be either
autophosphorylated (state A) or oxidized (state OxA). The model also includes
an active state that is both oxidized and phosphorylated (state OxP).
(B) Simulated steady state APs under control conditions (0µM H2O2).
(C) Simulated APs, some of which exhibit EADs, under conditions of elevated
oxidant stress (200µM H2O2). Simulated APs are from a 2 s PCL pacing
protocol (ensemble of 12500 calcium release units). For each condition,
results for 10 consecutive APs following an initial 10 s of pacing are shown.
As these ROS-mediated effects need to be further exam-
ined, future studies will focus on establishing quantitative
links between cellular ROS and redox balance, CaMKII activity
and function, ECC, and whole-cell electrophysiology. Recently,
Gauthier et al. (2013a,b) developed mechanistic models of ROS
production and scavenging to investigate how these two com-
peting processes control ROS levels in cardiac mitochondria.
Simulations confirm the hypothesis that mitochondrial Ca2+
mismanagement leads to decreased scavenging resources and
accounts for ROS overflow as is believed to occur in heart failure
(Hill and Singal, 1996). Notably, the ROS regulation module of
Gauthier et al. (2013b) enables its use in larger scale heart mod-
els designed to simulate and study how mitochondrial ROS and
the functional consequences of its accumulation, such as CaMKII
oxidation, regulate cellular physiological function, AP properties,
and arrhythmogenesis.
CONCLUSION
Integrative modeling of cardiac ECC, cell signaling, and myocyte
physiology has played a critical role in revealing mechanis-
tic insights across a range of biological scales. With respect to
CaMKII function at the smallest scale, models have shed light
on how Ca2+ ions, CaM, CaMKII, LCCs, and RyRs interact in
the cardiac dyadic junction both at rest and during triggered ECC
events. On an intermediate scale, models have predicted the con-
sequences of normal and abnormal CaMKII signaling on whole-
cell Ca2+ cycling, effects of ROS imbalance, AP shape, and the
generation of cellular arrhythmias such as EADs. Incorporation of
these cellular models into higher scale tissue simulations has pro-
vided important insight into the relationship between CaMKII
function, electrical wave conduction velocity, and the emergence
of arrhythmogenic substrates in diseased tissue. The continuum
of biological scales spanned by these models allows for the devel-
opment of multiscale approaches whereby we can predict and
understand the emergence of macroscale phenotypes as a conse-
quence of CaMKII-mediated molecular signaling events. A great
deal of evidence now implicates CaMKII as a nexus point linking
heart failure and arrhythmias (Swaminathan et al., 2012), iden-
tifying it as a prime target for antiarrhythmic therapies (Fischer
et al., 2013). Despite this growing body of evidence, the model-
ing studies presented here demonstrate that it remains difficult
to identify which of the many CaMKII target proteins are pri-
marily responsible for the functional changes that increase the
likelihood of arrhythmia development. Some studies (Hund et al.,
2008; Soltis and Saucerman, 2010; Zang et al., 2013; Morotti
et al., 2014) identify phosphorylation of RyRs, which leads to ele-
vated SR Ca2+ leak and/or increased likelihood of spontaneous
Ca2+ release events and DADs, as the key mechanism underlying
arrhythmogenesis. Others (Hashambhoy et al., 2010; Foteinou
et al., 2013) predict that LCC phosphorylation, which leads to ele-
vated channel open probability via high activity gating, plays the
predominant role by altering whole cell Ca2+ levels and AP prop-
erties, including the appearance of EADs. These mechanisms may
co-exist in heart failure, and it is likely that both play an impor-
tant role. Moreover, CaMKII modulation of other targets such as
PLB, INa, and K+ currents, many of which have been incorporated
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into the above cell models, adds additional layers of complexity to
the task of interpreting and predicting the mechanisms by which
CaMKII signaling alters cardiac function in health and disease.
As a result of the breadth and diversity of CaMKII targets, strate-
gies that involve broad inhibition of CaMKII activity will impact
and alter the function of many cellular subsystems, with com-
plex consequences that may not all be beneficial. As mathematical
models of CaMKII signaling in the cardiac dyad and beyond are
further developed, they will play a key role in identifying target-
specific therapeutic strategies for improving myocardial function
and reducing arrhythmias.
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